american diabetes association history of pancreatitis glp-1 receptor agonist The Use Glucagon-like Peptide-1 Agonists in Patients with Type 2 Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study american diabetes association pancreatitis history

At the bottom of the site, a disclaimer reads: Individuals appearing in advertisements may be actors or AI portraying doctors and are not licensed medical professionals. Last May, Futurism documented that MEDVis website featured AI-generated patient photos, deepfaked before-and-after weight loss images (traced to photos that had circulated online for years with faces swapped by AI), AI-generated Ozempic box imagery with clear errors

Staying well-hydrated and following gradual titration schedules can improve tolerability

Whether the same will extend to humans remains to be seen, but the authors claim their study "provides a strategy for diabetes prevention." The study was published in Nature Microbiology

Postgrad Med J 96(1133):156161 Singh K, Aulakh SK, Nijjar GS, Singh S, Sandhu APS, Luthra S, et al (2024) Rebalancing the gut: glucagon-like peptide-1 agonists as a strategy for obesity and metabolic health

Implications for employers: GLP-1 medications can cause GI problems and that is why starting doses are gradually increased

The current is a meta-analysis of trial data, and we acknowledge the superiority of patient-level meta-analysis